Efgartigimod
argenx
[' ibru', 'enhance,(-enhance 3),(-enhance-3),(-enhance3),(-enhanced),(-enahnces),(-enhancem),(-enhancer)']
#ash22 plenary. broome, et al. efgartigimod is an fcrn inhibitor enhances anti-platelet igg degradation. advance iv, rct of efgartimod vs placebo in chronic/persistent itp. 22% vs 7% sustained platelet response. concern over hypogam. 
Sarah Cannon Cancer Blood Cancer Network;
 #NIHBMTLateEffects   #Celltherapy #HSCT #BMT #Survivorship; Tweets/opinions are personal